Beaird Harris Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.6K Sell
480
-3
-0.6% -$242 ﹤0.01% 281
2026
Q1
$41.8K Hold
483
﹤0.01% 260
2025
Q4
$46.4K Sell
483
-18
-4% -$1.75K ﹤0.01% 257
2025
Q3
$47.7K Buy
501
+11
+2% +$1.01K ﹤0.01% 252
2025
Q2
$42.7K Buy
490
+165
+51% +$14K ﹤0.01% 261
2025
Q1
$29.2K Hold
325
﹤0.01% 273
2024
Q4
$26K Buy
+325
New +$28.1K ﹤0.01% 290
2024
Q2
Sell
-82
Closed -$7.15K 769
2024
Q1
$7.15K Sell
82
-160
-66% -$13.7K ﹤0.01% 359
2023
Q4
$19.9K Buy
+242
New +$18.4K ﹤0.01% 261
2023
Q1
Sell
-79
Closed -$6.14K 639
2022
Q4
$6.14K Buy
+79
New +$6.4K ﹤0.01% 383
2022
Q3
Sell
-187
Closed -$17K 514
2022
Q2
$17K Buy
187
+69
+58% +$6.99K ﹤0.01% 218
2022
Q1
$13K Sell
118
-1,924
-94% -$203K ﹤0.01% 294
2021
Q4
$211K Buy
+2,042
New +$236K 0.08% 115

Other funds holding MDT

Beaird Harris Wealth Management's MDT Position: Q2 2026 in Review

Beaird Harris Wealth Management reduced its Medtronic (MDT) stake by 0.62% in Q2 2026, selling an estimated $242 and leaving 480 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Beaird Harris Wealth Management first reported a position in MDT in Q4 2021 and has held it in 13 quarters since. The position peaked at $211K in Q4 2021. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Beaird Harris Wealth Management held 480 shares of Medtronic worth $37.6K as of Q2 2026.
  • Beaird Harris Wealth Management sold 3 Medtronic shares in Q2 2026, an estimated $242.
  • Medtronic made up ﹤0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #281 holding.
  • Beaird Harris Wealth Management first reported a position in Medtronic in Q4 2021 and has held it in 13 quarters since.
  • Beaird Harris Wealth Management's Medtronic position peaked at $211K in Q4 2021.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.